Form 8-K - Current report:
SEC Accession No. 0001564590-22-018871
Filing Date
2022-05-09
Accepted
2022-05-09 16:10:26
Documents
15
Period of Report
2022-05-09
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K hrtx-8k_20220509.htm   iXBRL 8-K 35369
2 EX-99.1 hrtx-ex991_6.htm EX-99.1 224980
3 GRAPHIC gbkawq1hgjr3000002.jpg GRAPHIC 32487
4 GRAPHIC gbkawq1hgjr3000001.jpg GRAPHIC 32648
  Complete submission text file 0001564590-22-018871.txt   494395

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA hrtx-20220509.xsd EX-101.SCH 5585
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE hrtx-20220509_lab.xml EX-101.LAB 19329
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE hrtx-20220509_pre.xml EX-101.PRE 11483
9 EXTRACTED XBRL INSTANCE DOCUMENT hrtx-8k_20220509_htm.xml XML 3557
Mailing Address 4242 CAMPUS POINT COURT, SUITE 200 SAN DIEGO CA 92121
Business Address 4242 CAMPUS POINT COURT, SUITE 200 SAN DIEGO CA 92121 8582514400
HERON THERAPEUTICS, INC. /DE/ (Filer) CIK: 0000818033 (see all company filings)

EIN.: 942875566 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33221 | Film No.: 22905018
SIC: 2834 Pharmaceutical Preparations